Liminatus Pharma, Inc. - 8-K Filing
Liminatus Pharma believes it has stockholders' equity in excess of $2.5 million following its merger with InnocsAI LLC and is awaiting Nasdaq compliance determination. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $LIMN